Adaptimmune Therapeutics
(NASDAQ:ADAP)
$1.0901
-0.0499[-4.38%]
At close: May 10
$1.0901
0[0.00%]
After Hours: 7:43PM EDT
Q1 2024 Earnings in 3 days from now on Wed May 15th, before the market open
Conference call scheduled in 3 days at 8:00 AM Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Adaptimmune Therapeutics Stock (NASDAQ:ADAP), Quotes and News Summary

Adaptimmune Therapeutics Stock (NASDAQ: ADAP) stock price, news, charts, stock research, profile.

Open$1.130
Close$1.120
Volume / Avg.531.725K / 1.486M
Day Range1.080 - 1.210
52 Wk Range0.420 - 2.050
Market Cap$278.588M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
43
Short Interest
2%
Days to Cover2.58

Recent News

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.
Avi Kapoor
Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Friday.
Avi Kapoor
Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
1.8
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ADAP
ZURA

FAQ

Q

How do I buy Adaptimmune Therapeutics (ADAP) stock?

A

You can purchase shares of Adaptimmune Therapeutics (NASDAQ: ADAP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Adaptimmune Therapeutics's (ADAP) competitors?

A

Other companies in Adaptimmune Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Precigen (NASDAQ:PGEN), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO) and Opthea (NASDAQ:OPT).

Q

What is the target price for Adaptimmune Therapeutics (ADAP) stock?

A

The latest price target for Adaptimmune Therapeutics (NASDAQ: ADAP) was reported by Barclays on Thursday, August 10, 2023. The analyst firm set a price target for 1.00 expecting ADAP to fall to within 12 months (a possible -8.27% downside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Adaptimmune Therapeutics (ADAP)?

A

The stock price for Adaptimmune Therapeutics (NASDAQ: ADAP) is $1.0901 last updated May 10, 2024 at 7:43 PM EDT.

Q

Does Adaptimmune Therapeutics (ADAP) pay a dividend?

A

There are no upcoming dividends for Adaptimmune Therapeutics.

Q

When is Adaptimmune Therapeutics (NASDAQ:ADAP) reporting earnings?

A

Adaptimmune Therapeutics’s Q2 earnings are confirmed for Wednesday, August 7, 2024.

Q

Is Adaptimmune Therapeutics (ADAP) going to split?

A

There is no upcoming split for Adaptimmune Therapeutics.

Q

What sector and industry does Adaptimmune Therapeutics (ADAP) operate in?

A

Adaptimmune Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch